AAC Award Winners, 2001 (The Clinical Chemist‪)‬

AACC Award for Outstanding Contributions to Clinical Chemistry, Sponsored by Bayer Diagnostics Peter Wilding, PhD, FACB, received his Bachelor of Science with Honors in Medical Biochemistry in 1961 and his PhD in Clinical Chemistry in 1965, both from the University of Birmingham, United Kingdom. His PhD thesis described and characterized the first case of "macro-amylasemia" and led to worldwide studies on macroenzymes. From 1965 to 1967, he was an Assistant Professor in the Department of Medicine of the University of Southern California in Los Angeles, CA. In 1967, he returned to the United Kingdom to gain further training in clinical chemistry at the Queen Elizabeth Medical Centre, Birmingham, England. From 1969 to 1972, he was Director of Pathology at the BUPA Medical Centre in London, following which he returned to Birmingham as Deputy Director of the Wolfson Research Laboratories at the University of Birmingham, where he served until he emigrated to the United States in 1977. During this period his research concentrated on the characterization of serum enzymes and the development of diagnostic methods and instruments.